Researchers reveal patients with inflammatory bowel disease are 28% more likely to develop Parkinson's disease. However, an anti-inflammatory treatment used to help those with IBD can significantly decrease the risk of developing the neurodegenerative disease.
Researchers report they have successfully erased damage caused by Apoe4 in Alzheimer's patients by altering the gene into a harmless Apoe3-like version.
Researchers report a drug developed to target amyloid plaques in those with Alzheimer's does not significantly slow cognitive decline.
Alzheimer's risk is increased for those with anosognosia, a condition in which sufferers are unaware they are experiencing memory loss.
A new study in Scientific Reports reports T.gonfii infection may alter, or even amplify some neurological disorders including Alzheimer's and Parkinson's disease.
According to researchers, the key to retaining information is to relate it to something meaningful rather than to repeat it parrot fashion.
Researchers have identified two drugs, including one in trial as an anti-cancer drug, that appears to prevent neurodegeneration.
Researchers have developed a new antibody design that can increase the uptake of antibodies to the brain by almost a 100 fold.